Intratumoral patterns of clonal evolution in gliomas

Neurogenetics

Volumn 11, Issue 2, 2010, Pages 227-239

  Vital, Ana Luísa ^a,b   Tabernero, Maria Dolores ^c,d,e   Crespo, Inês ^a,b   Rebelo, Olinda ^f   Tão, Hermínio ^f   Gomes, Fernando ^f   Lopes, Maria Celeste ^a,b   Orfao, Alberto ^d  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^d CSIC   (Spain)

^e IECSCYL   (Spain)

^f CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Clonal evolution; Cytogenetics; Glioma; Intratumoral heterogeneity

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER STAGING; CELL CLONE; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME LOSS; CLONE; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENETIC ANALYSIS; GLIOMA; HISTOPATHOLOGY; HUMAN; INTRATUMORAL CLONAL EVOLUTION; MAJOR CLINICAL STUDY; MALE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; SURVIVAL; TETRAPLOIDY; TUMOR BIOPSY; TUMOR CELL; TUMOR CLASSIFICATION; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CYTOGENETIC ANALYSIS; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; SURVIVAL RATE; YOUNG ADULT;

EID: 77954658610     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10048-009-0217-x     Document Type: Article

References (59)

1. Miller CR, Perry A (2007) Glioblastoma. Arch Pathol Lab Med131:397-406
2. Ohgaki H, Kleihues P (2005) Epidemiology and etiology ofgliomas. Acta Neuropathol 109:93-108
3. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) WHOclassification of tumours of the central nervous system. IARC,Lyon
4. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN et al(2001) Malignant glioma: genetics and biology of a grave matter.Genes Dev 15:1311-1333
5. Wolff JE, Berrak S, Koontz Webb SE, Zhang M (2008)Nitrosourea efficacy in high-grade glioma: a survival gainanalysis summarizing 504 cohorts with 24193 patients. J Neurooncol88:57-63
6. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B et al(2005) Radiotherapy plus concomitant and adjuvant temozolomidefor glioblastoma. N Engl J Med 352:987-996
7. Burton EC, Lamborn KR, Feuerstein BG, Prados M, Scott J et al(2002) Genetic aberrations defined by comparative genomichybridization distinguish long-term from typical survivors ofglioblastoma. Cancer Res 62:6205-6210
8. Fuller CE, Schmidt RE, Roth KA, Burger PC, Scheithauer BWet al (2003) Clinical utility of fluorescence in situ hybridization(FISH) in morphologically ambiguous gliomas with hybridoligodendroglial/astrocytic features. J Neuropathol Exp Neurol62:1118-1128
9. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH et al(2006) Molecular subclasses of high-grade glioma predict prognosis,delineate a pattern of disease progression, and resemblestages in neurogenesis. Cancer Cell 9:157-173
10. Kramar F, Zemanova Z, Michalova K, Babicka L, Ransdorfova Set al (2007) Cytogenetic analyses in 81 patients with braingliomas: correlation with clinical outcome and morphologicaldata. J Neurooncol 84:201-211
11. Mizoguchi M, Betensky RA, Batchelor TT, Bernay DC, LouisDN et al (2006) Activation of STAT3, MAPK, and AKT inmalignant astrocytic gliomas: correlation with EGFR status,tumor grade, and survival. J Neuropathol Exp Neurol 65:1181-1188
12. Homma T, Fukushima T, Vaccarella S, Yonekawa Y, Di Patre PLet al (2006) Correlation among pathology, genotype, and patientoutcomes in glioblastoma. J Neuropathol Exp Neurol 65:846-854
13. Korshunov A, Sycheva R, Golanov A (2005) The prognosticrelevance of molecular alterations in glioblastomas for patientsage
14. Jeon YK, Park K, Park CK, Paek SH, Jung HW et al (2007)Chromosome 1p and 19q status and p53 and p16 expressionpatterns as prognostic indicators of oligodendroglial tumors: aclinicopathological study using fluorescence in situ hybridization.Neuropathology 27:10-20
15. Walker C, du Plessis DG, Joyce KA, Machell Y, Thomson-Hehir Jet al (2003) Phenotype versus genotype in gliomas displayinginter- or intratumoral histological heterogeneity. Clin Cancer Res9:4841-4851
16. Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD et al (2005)Gene expression profiling reveals molecularly and clinicallydistinct subtypes of glioblastoma multiforme. Proc Natl AcadSci U S A 102:5814-5819
17. Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG et al(2003) Gene expression-based classification of malignant gliomascorrelates better with survival than histological classification.Cancer Res 63:1602-1607
18. Koschny R, Koschny T, Froster UG, Krupp W, Zuber MA (2002)Comparative genomic hybridization in glioma: a meta-analysis of509 cases. Cancer Genet Cytogenet 135:147-159
19. Wiltshire RN, Herndon JE 2nd, Lloyd A, Friedman HS, BignerDD et al (2004) Comparative genomic hybridization analysis ofastrocytomas: prognostic and diagnostic implications. J MolDiagn 6:166-179
20. Fuller CE, Wang H, Zhang W, Fuller GN, Perry A (2002) Highthroughputmolecular profiling of high-grade astrocytomas: theutility of fluorescence in situ hybridization on tissue microarrays(TMA-FISH). J Neuropathol Exp Neurol 61:1078-1084
21. Cowell JK, Matsui S, Wang YD, LaDuca J, Conroy J et al (2004)Application of bacterial artificial chromosome array-based comparativegenomic hybridization and spectral karyotyping to theanalysis of glioblastoma multiforme. Cancer Genet Cytogenet151:36-51
22. Kamiryo T, Tada K, Shiraishi S, Shinojima N, Nakamura H et al(2002) Analysis of homozygous deletion of the p16 gene andcorrelation with survival in patients with glioblastoma multiforme.J Neurosurg 96:815-822
23. Okada Y, Hurwitz EE, Esposito JM, Brower MA, Nutt CL et al(2003) Selection pressures of TP53 mutation and microenvironmentallocation influence epidermal growth factor receptorgene amplification in human glioblastomas. Cancer Res 63:413-416
24. Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J et al (2002)Correlation of histology and molecular genetic analysis of 1p,19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocyticand oligodendroglial tumors. Clin Cancer Res 8:196-201
25. Liu L, Ichimura K, Pettersson EH, Goike HM, Collins VP (2000)The complexity of the 7p12 amplicon in human astrocyticgliomas: detailed mapping of 246 tumors. J Neuropathol ExpNeurol 59:1087-1093
26. Backlund LM, Nilsson BR, Goike HM, Schmidt EE, Liu L et al(2003) Short postoperative survival for glioblastoma patients witha dysfunctional Rb1 pathway in combination with no wild-typePTEN. Clin Cancer Res 9:4151-4158
27. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T et al(2004) Genetic pathways to glioblastoma: a population-basedstudy. Cancer Res 64:6892-6899
28. Ohgaki H, Kleihues P (2007) Genetic pathways to primary andsecondary glioblastoma. Am J Pathol 170:1445-1453
29. Reifenberger J, Ring GU, Gies U, Cobbers L, Oberstrass J et al(1996) Analysis of p53 mutation and epidermal growth factorreceptor amplification in recurrent gliomas with malignantprogression. J Neuropathol Exp Neurol 55:822-831
30. Fulci G, Ishii N, Maurici D, Gernert KM, Hainaut P et al (2002)Initiation of human astrocytoma by clonal evolution of cells withprogressive loss of p53 functions in a patient with a 283H TP53germ-line mutation: evidence for a precursor lesion. Cancer Res62:2897-2905
31. Sayagues JM, Tabernero MD, Maillo A, Espinosa A, Rasillo Aet al (2004) Intratumoral patterns of clonal evolution in meningiomasas defined by multicolor interphase fluorescence in situhybridization (FISH): is there a relationship between histopathologicallybenign and atypical/anaplastic lesions? J Mol Diagn6:316-325
32. Harada K, Nishizaki T, Ozaki S, Kubota H, Ito H et al (1998)Intratumoral cytogenetic heterogeneity detected by comparativegenomic hybridization and laser scanning cytometry in humangliomas. Cancer Res 58:4694-4700
33. Wemmert S, Romeike BF, Ketter R, Steudel WI, Zang KD et al(2006) Intratumoral genetic heterogeneity in pilocytic astrocytomasrevealed by CGH-analysis of microdissected tumor cells andFISH on tumor tissue sections. Int J Oncol 28:353-360
34. Lopez-Gines C, Cerda-Nicolas M, Gil-Benso R, Pellin A, Lopez-Guerrero JA et al (2005) Association of chromosome 7,chromosome 10 and EGFR gene amplification in glioblastomamultiforme. Clin Neuropathol 24:209-218
35. Necesalova E, Vranova V, Kuglik P, Cejpek P, Jarosova M et al(2007) Incidence of the main genetic markers in glioblastomamultiforme is independent of tumor topology. Neoplasma 54:212-218
36. Shinojima N, Tada K, Shiraishi S, Kamiryo T, Kochi M et al(2003) Prognostic value of epidermal growth factor receptor inpatients with glioblastoma multiforme. Cancer Res 63:6962-6970
37. McLendon RE, Turner K, Perkinson K, Rich J (2007) Secondmessenger systems in human gliomas. Arch Pathol Lab Med131:1585-1590
38. Scaltriti M, Baselga J (2006) The epidermal growth factorreceptor pathway: a model for targeted therapy. Clin Cancer Res12:5268-5272
39. Li L, Ross AH (2007) Why is PTEN an important tumorsuppressor? J Cell Biochem 102:1368-1374
40. Hlobilkova A, Ehrmann J, Sedlakova E, Krejci V, Knizetova P etal (2007) Could changes in the regulation of the PI3K/PKB/Aktsignaling pathway and cell cycle be involved in astrocytic tumorpathogenesis and progression? Neoplasma 54:334-341
41. Rao RD, James CD (2004) Altered molecular pathways ingliomas: an overview of clinically relevant issues. Semin Oncol31:595-604
42. Ohtani N, Yamakoshi K, Takahashi A, Hara E (2004) Thep16INK4a-RB pathway: molecular link between cellular senescenceand tumor suppression. J Med Invest 51:146-153
43. Jones DT, Kocialkowski S, Liu L, Pearson DM, Backlund LMet al (2008) Tandem duplication producing a novel oncogenicBRAF fusion gene defines the majority of pilocytic astrocytomas.Cancer Res 68:8673-8677
44. Bar EE, Lin A, Tihan T, Burger PC, Eberhart CG (2008) Frequentgains at chromosome 7q34 involving BRAF in pilocytic astrocytoma.J Neuropathol Exp Neurol 67:878-887
45. Jendrossek V, Kugler W, Erdlenbruch B, Eibl H, Lakomek M(2001) Induction of differentiation and tetraploidy by long-termtreatment of C6 rat glioma cells with erucylphosphocholine. Int JOncol 19:673-680
46. Ganem NJ, Storchova Z, Pellman D (2007) Tetraploidy, aneuploidyand cancer. Curr Opin Genet Dev 17:157-162
47. Liu Y, Yeh N, Zhu XH, Leversha M, Cordon-Cardo C et al (2007)Somatic cell type specific gene transfer reveals a tumor-promotingfunction for p21(Waf1/Cip1). EMBO J 26:4683-4693
48. Tews B, Felsberg J, Hartmann C, Kunitz A, Hahn M et al (2006)Identification of novel oligodendroglioma-associated candidatetumor suppressor genes in 1p36 and 19q13 using microarraybasedexpression profiling. Int J Cancer 119:792-800
49. Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M(2005) Allelic losses at 1p36 and 19q13 in gliomas: correlationwith histologic classification, definition of a 150-kb minimaldeleted region on 1p36, and evaluation of CAMTA1 as acandidate tumor suppressor gene. Clin Cancer Res 11:1119-1128
50. Weller M, Berger H, Hartmann C, Schramm J, Westphal M et al(2007) Combined 1p/19q loss in oligodendroglial tumors: predictiveor prognostic biomarker? Clin Cancer Res 13:6933-6937
51. Jenkins RB, Blair H, Ballman KV, Giannini C, Arusell RM et al(2006) A t(1;19)(q10;p10) mediates the combined deletions of 1pand 19q and predicts a better prognosis of patients witholigodendroglioma. Cancer Res 66:9852-9861
52. Felsberg J, Erkwoh A, Sabel MC, Kirsch L, Fimmers R et al(2004) Oligodendroglial tumors: refinement of candidate regionson chromosome arm 1p and correlation of 1p/19q status withsurvival. Brain Pathol 14:121-130
53. Jenkins RB, Curran W, Scott CB, Cairncross G (2001) Pilotevaluation of 1p and 19q deletions in anaplastic oligodendrogliomascollected by a national cooperative cancer treatment group.Am J Clin Oncol 24:506-508
54. Ohgaki H, Kleihues P (2005) Population-based studies onincidence, survival rates, and genetic alterations in astrocytic andoligodendroglial gliomas. J Neuropathol Exp Neurol 64:479-489
55. Qu M, Olofsson T, Sigurdardottir S, You C, Kalimo H et al (2007)Genetically distinct astrocytic and oligodendroglial components inoligoastrocytomas. Acta Neuropathol 113:129-136
56. Reddy KS (2008) Assessment of 1p/19q deletions by fluorescence insitu hybridization in gliomas. Cancer Genet Cytogenet 184:77-86
57. Jones DT, Ichimura K, Liu L, Pearson DM, Plant K et al (2006)Genomic analysis of pilocytic astrocytomas at 0.97 Mb resolutionshows an increasing tendency toward chromosomal copynumber change with age. J Neuropathol Exp Neurol 65:1049-1058
58. Lima-Ramos V, Pacheco-Figueiredo L, Costa S, Pardal F, Silva Aet al (2008) TP53 codon 72 polymorphism in susceptibility,overall survival, and adjuvant therapy response of gliomas.Cancer Genet Cytogenet 180:14-19
59. ChangY, Berenson JR,Wang Z, Deuel TF (2006) Dominant negativepleiotrophin induces tetraploidy and aneuploidy in U87MG humanglioblastoma cells. Biochem Biophys Res Commun 351:336-339